Charles River Laboratories: Retained Earnings, ROE, And Debt Management Will Shape Its Future Amid Weak Demand
Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, indicating future capital deployment.
Billion-dollar pharma company to close Triangle sites
Charles River Laboratories is closing facilities in Durham and Research Triangle Park. Charles River expects revenue to decline organically this year amid restructuring efforts. A global pharma ...
Pharma researcher Charles River to close Durham facility, lay off dozens
The company told state officials that it plans to initially lay off at least 31 employees as it works to close its Pathology Associates International office on Stirrup Creek Drive.
Charles River Laboratories stock hits 52-week low at $160.73
Charles River Laboratories International Inc. (CRL) stock has reached a new 52-week low, touching down at $160.73. This ...